Literature DB >> 22115779

NMR structure of human thymosin alpha-1.

Miguel-Angel Elizondo-Riojas1, Steven M Chamow, Cynthia W Tuthill, David G Gorenstein, David E Volk.   

Abstract

800 MHz NMR structure of the 28-residue peptide thymosin alpha-1 in 40% TFE/60% water (v/v) has been determined. Restrained molecular dynamic simulations with an explicit solvent box containing 40% TFE/60% TIP3P water (v/v) were used, in order to get the 3D model of the NMR structure. We found that the peptide adopts a structured conformation having two stable regions: an alpha-helix region from residues 14 to 26 and two double β-turns in the N-terminal twelve residues which form a distorted helical structure.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22115779      PMCID: PMC3419376          DOI: 10.1016/j.bbrc.2011.11.041

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages.

Authors:  Arevik Mosoian; Avelino Teixeira; Anthony A High; Robert E Christian; Donald F Hunt; Jeffrey Shabanowitz; Xinyan Liu; Mary Klotman
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Prothymosin-alpha inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction.

Authors:  Arevik Mosoian; Avelino Teixeira; Colin S Burns; Leif E Sander; G Luca Gusella; Cijiang He; J Magarian Blander; Paul Klotman; Mary E Klotman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

3.  VMD: visual molecular dynamics.

Authors:  W Humphrey; A Dalke; K Schulten
Journal:  J Mol Graph       Date:  1996-02

4.  A revised set of potentials for beta-turn formation in proteins.

Authors:  E G Hutchinson; J M Thornton
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

5.  The combined treatment of interferon alpha-2a and thymosin alpha 1 for chronic hepatitis C: the 48 weeks end of treatment results.

Authors:  P Kullavanuaya; S Treeprasertsuk; D Thong-Ngam; K Chaermthai; S Gonlachanvit; P Suwanagool
Journal:  J Med Assoc Thai       Date:  2001-06

6.  The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial.

Authors:  S Iino; J Toyota; H Kumada; K Kiyosawa; S Kakumu; M Sata; H Suzuki; E B Martins
Journal:  J Viral Hepat       Date:  2005-05       Impact factor: 3.728

Review 7.  Current approaches to diagnosis and treatment of invasive aspergillosis.

Authors:  Brahm H Segal; Thomas J Walsh
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

8.  Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance.

Authors:  Luigina Romani; Francesco Bistoni; Katia Perruccio; Claudia Montagnoli; Roberta Gaziano; Silvia Bozza; Pierluigi Bonifazi; Giovanni Bistoni; Guido Rasi; Andrea Velardi; Francesca Fallarino; Enrico Garaci; Paolo Puccetti
Journal:  Blood       Date:  2006-06-01       Impact factor: 22.113

9.  The conformation of peptide thymosin alpha 1 in solution and in a membrane-like environment by circular dichroism and NMR spectroscopy. A possible model for its interaction with the lymphocyte membrane.

Authors:  A Grottesi; M Sette; T Palamara; G Rotilio; E Garaci; M Paci
Journal:  Peptides       Date:  1998       Impact factor: 3.750

View more
  5 in total

1.  Bioactive Thymosin Alpha-1 Does Not Influence F508del-CFTR Maturation and Activity.

Authors:  Andrea Armirotti; Valeria Tomati; Elizabeth Matthes; Guido Veit; Deborah M Cholon; Puay-Wah Phuan; Clarissa Braccia; Daniela Guidone; Martina Gentzsch; Gergely L Lukacs; Alan S Verkman; Luis J V Galietta; John W Hanrahan; Nicoletta Pedemonte
Journal:  Sci Rep       Date:  2019-07-16       Impact factor: 4.379

Review 2.  Thymosin alpha 1: A comprehensive review of the literature.

Authors:  Asimina Dominari; Donald Hathaway Iii; Krunal Pandav; Wanessa Matos; Sharmi Biswas; Gowry Reddy; Sindhu Thevuthasan; Muhammad Adnan Khan; Anoopa Mathew; Sarabjot Singh Makkar; Madiha Zaidi; Michael Maher Mourad Fahem; Renato Beas; Valeria Castaneda; Trissa Paul; John Halpern; Diana Baralt
Journal:  World J Virol       Date:  2020-12-15

3.  Potential anti neuro-inflammatory effect of BioCen-128 in animal models of dementia.

Authors:  Nashelly Esquivel; Yenela García; Roberto Menéndez; Teidy E García; Ana R Morales; Claudio Rodríguez
Journal:  Animal Model Exp Med       Date:  2022-08-15

4.  A tumor-penetrating peptide modification enhances the antitumor activity of thymosin alpha 1.

Authors:  Xingzhen Lao; Meng Liu; Jiao Chen; Heng Zheng
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

5.  Thymosin α1 Interacts with Hyaluronic Acid Electrostatically by Its Terminal Sequence LKEKK.

Authors:  Walter Mandaliti; Ridvan Nepravishta; Francesca Pica; Paola Sinibaldi Vallebona; Enrico Garaci; Maurizio Paci
Journal:  Molecules       Date:  2017-10-27       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.